Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
<< Back to Results
The purpose of this study is to find out how effective and safe CSL112 (study drug) is at reducing the risk of death from heart related events, having another heart attack or stroke in patients who have experienced a recent myocardial infarction (heart attack).
View this clinical trail on ClinicalTrials.gov.
Essentia Health Duluth
For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.
Last Updated: 10/16/2018